CRTC1 forms fusion transcripts with mastermind-like 2 (MAML2) that function as transcriptional coactivators driving mucoepidermoid carcinoma development (37), including in lungs (38). The gene discussed is MAML2; the disease is mucoepidermoid carcinoma.